| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2882268 | The Annals of Thoracic Surgery | 2018 | 8 Pages |
Abstract
These findings suggest that simvastatin inhibited CPB-induced toll-like receptor 4 upregulation and nuclear factor-κB activation, efficaciously reduing the pulmonary inflammatory response after CPB.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hongtao MD, Yi MD, Hao MD, Guohua MD, Jianjun MD, Hua MD,